Patrick W. Linson
Papers
1
Total Citations
128
H-Index
1
About
Patrick W. Linson is a leading radiation oncologist whose research has fundamentally advanced the use of stereotactic body radiation therapy (SBRT) for prostate cancer. His work centers on the radiobiology of extreme hypofractionation—delivering very high doses of radiation in fewer, more intense treatments—and its application to improve patient outcomes. Linson’s most impactful contribution is his landmark multicenter trial, published in 2018, which demonstrated that dose-escalated SBRT can be safely and effectively administered for low- and intermediate-risk prostate cancer. This study, with 128 citations, provided critical survival and toxicity endpoints that helped establish SBRT as a standard, non-invasive treatment option, offering patients a convenient alternative to conventional, longer radiation regimens. By proving the safety and efficacy of this approach across multiple institutions, Linson’s work has directly shaped clinical guidelines and expanded access to advanced radiotherapy. His research continues to influence the field, bridging the gap between radiobiological theory and practical, patient-centered cancer care.
Research Focus
Key Achievements
Top Papers
- 1